Advertisement

Topics

Companies Related to "Safety, Tolerability and Pharmacokinetic Profile of Levodopa Administered With Continuous Administration of ND0611" [Most Relevant Company Matches] RSS

21:17 EST 20th February 2019 | BioPortfolio

Here are the most relevant search results for "Safety, Tolerability and Pharmacokinetic Profile of Levodopa Administered With Continuous Administration of ND0611" found in our extensive corporate database of over 50,000 company records.

Showing "Safety Tolerability Pharmacokinetic Profile Levodopa Administered With Continuous" Companies 1–25 of 2,000+

Relevant

Androclus Therapeutics

Androclus Therapeutics is a clinical-stage biotechnology company developing first-in-class selective therapeutics for the treatment of autoimmune diseases, including rheumatoid arthritis (RA), multiple sclerosis (MS) and inflammatory bowel disease (IBD), based on a proprietary epitope-specific immunotherapy technology platform. The breakthrough technology platform has a potential of producing the ...


ALLOZYNE Inc.

Headquartered in Seattle, ALLOZYNE was established in late 2005, to commercialize proprietary biociphering technology that it licensed, on an exclusive basis, from the California Institute of Technology. The biociphering platforms, CAESAR and VIGENÈRE, are able to site specifically modify any protein sequence through the substitution or addition of non-...

Sonus Pharmaceuticals

SONUS PHARMACEUTICALS is focused on the development of drugs that provide better therapeutic alternatives for cancer patients,including improved efficacy,safety and tolerability,and are more convenient to use


Biologist Network

Each registered (french speaking) user in the directory has its own profile (for an example, click here). The user can access his profile at any time to modify it (or even to delete it). Each profile is also directly accessible via a web link. This web link can be use in the signature of an email.

ADVANCED VIRAL RESEARCH CORP

Advanced Viral Research Corp. (OTC Bulletin Board: ADVR), established in the mid-1980s, and headquartered in Yonkers, New York, is a biopharmaceutical firm dedicated to improving patients' lives by researching, developing, and bringing to market new and effective therapies for many serious diseases and disorders. With the commitment of expert leadership and skilled research scientists, ADVR is ag...

Lyndra, Inc.

Lyndra aims to fundamentally change the way patients take medicines through the development of oral, ultra-long-acting, sustained release oral therapies that drastically improve healthcare outcomes. The Lyndra platform was developed at the Massachusetts Institute of Technology, in the laboratory of Dr. Robert Langer in collaboration with the Bill and Melin...

Profile Therapeutics Inc

Many of our customers have known us for a long time as Medic-Aid, manufacturers of quality drug delivery systems for patients and the healthcare sector, for nearly 25 years. Profile Respiratory Systems is one of three companies within the Profile Therapeutics plc Group, all of whom share the same vision and values.We have taken the decision to come together as one brand: Profile.Our look may be di...

Protalex, Inc.

Protalex, Inc. is a clinical stage biopharmaceutical company that is developing a class of biopharmaceutical drugs for treating autoimmune and inflammatory diseases, including but not limited to, rheumatoid arthritis. Protalex’s lead product PRTX-100, which is formulated with a highly-purified form of staphylococcal protein A, has completed a Phase 1b...

Lyndra Inc.

Lyndra aims to fundamentally change the way patients take medicines through the development of oral, ultra-long-acting, sustained release oral therapies that drastically improve healthcare outcomes. The Lyndra platform is based on technology licensed from the Massachusetts Institute of Technology, originally developed in the laboratory of Dr. Robert Langer...

Sonus Pharmaceuticals, Inc.

Headquartered near Seattle, Washington, Sonus Pharmaceuticals, Inc. is focused on the development of cancer drugs that are designed to provide better efficacy, safety and tolerability, and ease of use. Sonus moved an oncology product candidate, SN2310, into a Phase 1 clinical trial in September 2006. For additional information on Sonus, including past news releases, please visit http://www.son...

TheraCoat

TheraCoat is a specialty pharmaceutical company founded in 2004 by uro-oncologists and biomaterial specialists. TheraCoat’s Board of Directors and Scientific Advisory Board feature renowned scientific experts in the fields of urology, pharma top executives and experienced business veterans; among them Prof. Belldegrun and Mr. Hurvitz, both TEVA Board ...

Profile Therapeutics plc

In 1994, the business was acquired by its management in order to progress the development of its innovative platform "intelligent inhalation" technology known as Adaptive Aerosol Delivery™ or "AAD™". In March 2000, Profile Therapeutics plc completed its IPO on the London Stock Exchange to exploit the opportunities presented by this technology. Profile Therapeutics plc now comprises three compl...

Chiasma (Israel), LTD

Chiasma develops new drug products based on its proprietary Transient Permeability Enhancer (TPE) technology, which enables oral delivery of macromolecules (up-to 20 kDa) and poorly-absorbed small molecules into the GI wall, portal system and then to the systemic circulation. Chiasma creates its internal pipeline by selecting approved macromolecules that are currently available in injectable form...

Hallux Incorporated

Hallux is developing an investigational micro-insert for subungual delivery and treatment of distal lateral subungual onychomycosis. The dosage form is biodegradable and delivers high concentrations of terbinafine hydrochloride directly and selectively to the site of infection over a period of time. Results from pilot studies are encouraging and suggest th...

Winston Pharmaceuticals, Inc.

Winston is a pharmaceutical company focused on pain control which is developing products for large pain control markets, as well as for niche markets, where there are still significant unmet needs for pain management options with improved efficacy, safety, and tolerability profiles. Winston's late stage product candidates include osteo- and rheumatoid arth...

Bayhill Therapeutics Inc

Bayhill Thereapeutics is a clinical-stage biopharmaceutical company at the forefront of developing novel and targeted treatment candidates for autoimmune diseases. Leveraging its proprietary therapeutic BHT-DNA™ platform, the Company’s product candidates have been designed to restore the immune system to its normal state, known as “tolerance,”...

ISPEX Exchange Inc

The ISPE catalogues and maintains categorical hypertext links to companies which supply scientific products and services to research scientists. Many companies also supply us with a profile and accordingly you will find that those companies have next to their listing. Clicking on this graphic will take you to their profile. If you wish to search through all ISPE site content, use the Search the I...

ThalesNano Nanotechnology Inc

ThalesNano is a world-leading provider of continuous process chemistry instruments in the rapidly developing market of laboratory and process scale flow reactors. The company has the widest portfolio of bench-top continuous process instruments. Its R&D 100 award winning H-Cube(R) continuous-flow hydrogenation reactor and the pilot plant scale version H-Cube Midi(TM) are used in hundreds of lab...

BioPharmaLink services

Basic Company profile (free): Your company will be considered for inclusion in our directory. You get 1 page with company information.Enhanced Company Profile: - To have your company included in our directory. - To add your services, offers, calls, company news and company contact persons to our market place - To get Priority listings of your company profile through search results of the company-...

Calabar AB

Calabar AB is a privately-held company committed to developing a pharmaceutical product addressing the great unmet needs of xerostomia "dry mouth". The company develops locally administered formulations of the cholinesterase inhibitor physostigmine, which has been shown to effectively increase salivary flow. Unlike systemically administered drugs, the local route of administration significantl...

Society of Chemical Industry

The Society of Chemical Industry (SCI) is a unique international forum where science meets business on independent, impartial ground. Anyone can join, and the Society offers a chance to share information between sectors as diverse as food and agriculture, pharmaceuticals, biotechnology, environmental science and safety. Originally established in 1881, SCI is a registered charity with individual Me...

PatientSafe Solutions, Inc.

PatientSafe Solutions, Inc. designs hardware and software solutions to provide patient safety and improve patient, family, and nurse satisfaction in hospitals. PatientSafe is creating a virtual Cone of Protection(TM) around the patient. The Cone of Protection will enable continuous protection against potential medication errors, hospital acquired infections, and patient falls in the hospital. Th...

Omnicell

Omnicell, Inc. (NASDAQ: OMCL) is a leading provider of systems and software solutions targeting patient safety and operational efficiency in healthcare facilities. Since 1992, Omnicell has worked with more than 1,600 healthcare facilities to enhance patient safety and allow clinicians to spend more time with their patients.Omnicell's medication-use product line includes solutions for the central p...

Cytheris SA

Cytheris is a privately held clinical-stage biopharmaceutical company focused on research and development of therapies for immune modulation.  These drugs aim at reconstituting and enhancing the immune system of patients suffering from cancer, chronic viral or bacterial infections such as HIV, HCV, and HBV or lympho-depleting treatments such as chemotherapy, radiotherapy, bone marrow transp...

Intec Pharma Ltd.

Intec Pharma Ltd. is a clinical stage biopharmaceutical company focused on developing drugs based on its proprietary Accordion Pill platform technology. The Company's Accordion Pill is an oral drug delivery system that is designed to improve the efficacy and safety of existing drugs and drugs in development by utilizing an efficient gastric retention and s...


More From BioPortfolio on "Safety, Tolerability and Pharmacokinetic Profile of Levodopa Administered With Continuous Administration of ND0611"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks